BIOREM Inc.
BIRMF
$1.44
-$0.1041-6.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -24.91% | -25.83% | 165.70% | 67.45% | 87.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -24.91% | -25.83% | 165.70% | 67.45% | 87.33% |
| Cost of Revenue | -17.81% | -3.83% | 144.65% | 66.55% | 36.01% |
| Gross Profit | -41.42% | -64.77% | 219.78% | 70.63% | 1,426.13% |
| SG&A Expenses | -20.17% | -7.31% | 147.62% | 32.85% | 30.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.33% | -4.93% | 144.97% | 59.96% | 35.19% |
| Operating Income | -87.76% | -89.20% | 297.32% | 340.66% | 169.80% |
| Income Before Tax | -89.79% | -92.21% | 328.51% | 445.85% | 161.92% |
| Income Tax Expenses | -89.63% | -89.90% | 328.62% | 445.56% | 161.95% |
| Earnings from Continuing Operations | -89.85% | -92.87% | 328.47% | 445.82% | 161.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -89.85% | -92.87% | 328.47% | 445.82% | 161.91% |
| EBIT | -87.76% | -89.20% | 297.32% | 340.66% | 169.80% |
| EBITDA | -69.28% | -86.98% | 295.77% | 240.68% | 187.93% |
| EPS Basic | -91.41% | -92.81% | 325.52% | 443.48% | 161.98% |
| Normalized Basic EPS | -91.30% | -92.19% | 326.11% | 446.15% | 162.16% |
| EPS Diluted | -90.07% | -117.34% | 286.16% | 386.96% | 153.01% |
| Normalized Diluted EPS | -89.92% | -91.64% | 302.75% | 392.31% | 153.60% |
| Average Basic Shares Outstanding | 18.80% | -0.64% | 0.65% | 0.00% | -0.36% |
| Average Diluted Shares Outstanding | 2.60% | -7.26% | 6.52% | 18.01% | 15.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |